[HTML][HTML] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

JA Bonner, PM Harari, J Giralt, N Azarnia… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a multinational, randomized study to compare radiotherapy alone
with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal growth …

[HTML][HTML] Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer

…, JL Lefèbvre, RH Greiner, J Giralt… - … England Journal of …, 2004 - Mass Medical Soc
Background We compared concomitant cisplatin and irradiation with radiotherapy alone as
adjuvant treatment for stage III or IV head and neck cancer. Methods After undergoing …

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between …

JA Bonner, PM Harari, J Giralt, RB Cohen… - The lancet …, 2010 - thelancet.com
Background Previous results from our phase 3 randomised trial showed that adding
cetuximab to primary radiotherapy increased overall survival in patients with locoregionally …

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study

…, D Marchal, JL Van Laethem, V Klein, J Giralt… - The lancet …, 2014 - thelancet.com
Background EORTC trial 22921 examined the addition of preoperative or postoperative
chemotherapy to preoperative radiotherapy in patients with rectal cancer. After a median follow-…

[PDF][PDF] Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02

LJ Peters, B O'Sullivan, J Giralt… - Journal of clinical …, 2010 - researchgate.net
… Peters, Brian O’Sullivan, Jordi Giralt, Thomas J. Fitzgerald, Andy Trotti, Jacques Bernier,
Jean Bourhis, Kally Yuen, Richard Fisher, and Danny Rischin … Peters, sanofi-aventis (C); …

Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor α expression in head and neck …

…, S Sauleda, J Anido, G Raspall, J Giralt… - Cancer research, 2001 - AACR
The expression of the activated mitogen-activated kinases/extracellular signal-regulatedkinases
(ERKs) ERK1 and ERK2 was characterized in 101 humanhead and neck squamous …

[PDF][PDF] Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART) …

D Rischin, LJ Peters, B O'Sullivan, J Giralt, R Fisher… - 2008 - academia.edu
… Peters, sanofi-aventis (C); Brian O’Sullivan, sanofi-aventis (C); Jordi Giralt, sanofi-aventis (C);
Richard Fisher, sanofi-aventis (C); Andy Trotti, sanofi-aventis (C); Jacques Bernier, sanofi-aventis …

[PDF][PDF] Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT …

…, L Gandola, T Björk-Eriksson, J Giralt… - Journal of clinical …, 2012 - researchgate.net
Purpose To compare event-free survival (EFS), overall survival (OS), pattern of relapse, and
hearing loss in children with standard-risk medulloblastoma treated by postoperative …

[HTML][HTML] Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement

…, J Corry, R Corvo, M Evans, AS Garden, J Giralt… - International Journal of …, 2020 - Elsevier
Purpose Because of the unprecedented disruption of health care services caused by the
COVID-19 pandemic, the American Society of Radiation Oncology (ASTRO) and the European …

Delineation of the primary tumour clinical target volumes (ctv-p) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: Airo, caca …

…, A Chen, A Eisbruch, M Feng, J Giralt… - Radiotherapy and …, 2018 - thegreenjournal.com
Purpose Few studies have reported large inter-observer variations in target volume selection
and delineation in patients treated with radiotherapy for head and neck squamous cell …